title: Reply to B.M. Strebel.
authors.affiliation: Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille; Centre Investigation Clinique, Marseille, France.
authors.forename: Fabrice
authors.initials: F
authors.lastname: Barlesi
authors.forename: Arnaud
authors.initials: A
authors.lastname: Scherpereel
authors.forename: Achim
authors.initials: A
authors.lastname: Rittmeyer
authors.forename: Antonio
authors.initials: A
authors.lastname: Pazzola
authors.forename: Joo-Hang
authors.initials: JH
authors.lastname: Kim
authors.forename: Myung-Ju
authors.initials: MJ
authors.lastname: Ahn
authors.forename: Joachim G J V
authors.initials: JG
authors.lastname: Aerts
authors.forename: Anders
authors.initials: A
authors.lastname: Vikström
authors.forename: Harry J M
authors.initials: HJ
authors.lastname: Groen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male